Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders

Lack of Medical Support in HIV Infection and Unstable Mood States

Psychological Reports ◽

10.2466/pr0.1997.81.2.635 ◽

1997 ◽

Vol 81 (2) ◽

pp. 635-639

Author(s):

Motoko Hayashi ◽

Isao Fukunishi

Keyword(s):

Social Support ◽

Depressive Symptoms ◽

Major Depression ◽

Hiv Infection ◽

Mood Disorders ◽

Early Stage ◽

Mood States ◽

Hiv Positive ◽

Medical Support ◽

Hiv Patients

This study examined what kinds of social support are related to mood states in a sample of 50 HIV-positive patients without AIDS (46 men and 4 women; M age 36.5 yr., SD = 9.8). In the early stage of HIV infection, HIV patients without AIDS may be prone to depressive symptoms although none of these HIV-positive patients' symptoms fulfilled the DSM-III-R Mood Disorders including Major Depression. The depressive symptoms were not significantly related to lack of ordinary social support such as friends and family but were significantly associated with dissatisfaction with HIV/AIDS-related medical support

Download Full-text

Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders

Life Sciences ◽

10.1016/j.lfs.2014.02.033 ◽

2014 ◽

Vol 102 (1) ◽

pp. 65-71 ◽

Cited By ~ 28

Author(s):

Heber Odebrecht Vargas ◽

Sandra Odebrecht Vargas Nunes ◽

Décio Sabbatini Barbosa ◽

Mateus Mendonca Vargas ◽

Ariane Cestari ◽

...

Keyword(s):

Metabolic Syndrome ◽

Major Depression ◽

Mood Disorders ◽

The Metabolic Syndrome

Download Full-text

Kleptomania, mood disorder and lithium

Arquivos de Neuro-Psiquiatria ◽

10.1590/s0004-282x1992000400023 ◽

1992 ◽

Vol 50 (4) ◽

pp. 543-546 ◽

Cited By ~ 4

Author(s):

Fábio Lopes Rocha ◽

Maria Elizabete Guimarães Rocha

Keyword(s):

Major Depression ◽

Mood Disorder ◽

Mood Disorders ◽

Pharmacological Treatment ◽

Lithium Therapy ◽

Bipolar Mood Disorder

Kleptomania has been found in association with major depression in a fairly large number of reports in recent years. We describe a patient with concurrent DSM-III-R Bipolar Mood Disorder and Kleptomania, whose symptoms remitted completely, apparently in response to lithium therapy, which raised the possibility that pharmacological treatment may benefit kleptomania. Further studies are needed to establish the possible relationship between kleptomania, mood disorders and lithium therapy.

Download Full-text

Complexity analysis of spontaneous brain activity in mood disorders: A magnetoencephalography study of bipolar disorder and major depression

Comprehensive Psychiatry ◽

10.1016/j.comppsych.2018.03.015 ◽

2018 ◽

Vol 84 ◽

pp. 112-117 ◽

Cited By ~ 6

Author(s):

Alberto Fernández ◽

Ali H. Al-Timemy ◽

Francisco Ferre ◽

Gabriel Rubio ◽

Javier Escudero

Keyword(s):

Bipolar Disorder ◽

Major Depression ◽

Mood Disorders ◽

Complexity Analysis ◽

Brain Activity ◽

Spontaneous Brain Activity

Download Full-text

Mood Disorders (Major Depression, Bipolar Disorder)

Geriatric Diseases ◽

10.1007/978-3-319-32700-6_73-1 ◽

2017 ◽

pp. 1-17

Author(s):

Nages Nagaratnam ◽

Kujan Nagaratnam ◽

Gary Cheuk

Keyword(s):

Bipolar Disorder ◽

Major Depression ◽

Mood Disorders

Download Full-text

Epidemiology of mood disorders

New Oxford Textbook of Psychiatry ◽

10.1093/med/9780199696758.003.0086 ◽

2012 ◽

pp. 645-650

Author(s):

Peter R. Joyce

Keyword(s):

Major Depression ◽

Mood Disorders ◽

Disease Burden ◽

Depressive Disorders ◽

Bipolar Disorders ◽

Developed Countries ◽

Disability Adjusted Life ◽

Life Years ◽

The World ◽

Unipolar Major Depression

The Global Burden of Disease, which is a comprehensive assessment of mortality and disability from diseases and injuries in 1990 and projected to 2020, highlights the importance of mood disorders for the world. Using the measure of disability-adjusted life years, it was determined that unipolar major depression was the fourth leading cause of disease burden in the world. It was also projected that, in the year 2020, unipolar major depression would be the second leading cause of disease burden in the world. Disabilityadjusted life years is based on both mortality and disability. If one looks at disability alone, then unipolar major depression was the leading cause of disability in the world in 1990, and bipolar disorder was the sixth leading cause. Across the world, 10.7 per cent of disability can be attributed to unipolar major depression and, in developed countries, unipolar major depression contributes to nearly 20 per cent of disease burden in women aged from 15 to 44 years. This chapter addresses bipolar disorders and depressive disorders, covering diagnostic issues, prevalence, comorbidity, use of health services, and risk factors for both types of disorder.

Download Full-text

Mood Disorders-Major Depression

Integrated Care ◽

10.1002/9781119276579.ch2 ◽

2016 ◽

pp. 25-54

Author(s):

Amy Bauer ◽

Patricia Areán

Keyword(s):

Major Depression ◽

Mood Disorders

Download Full-text

Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit

Epidemiologia e Psichiatria Sociale ◽

10.1017/s1121189x00001007 ◽

2009 ◽

Vol 18 (2) ◽

pp. 119-127 ◽

Cited By ~ 15

Author(s):

Bernardo Carpiniello ◽

Federica Pinna ◽

Gianluca Pillai ◽

Valentina Nonnoi ◽

Enrica Pisano ◽

...

Keyword(s):

Mental Health ◽

Major Depression ◽

Mood Disorders ◽

Clinical Sample ◽

Psychiatric Evaluation ◽

Routine Practice ◽

Obese Patients ◽

High Prevalence ◽

Axis I ◽

Treatment Of Obesity

SummaryAims – The study aims to evaluate the frequency of association between Axis I and II disorders according to DSMIVTR criteria and obesity, and use of mental health services in a clinical sample of patients attending a centre for the diagnosis and treatment of Obesity. Methods – 150 consecutive patients (32 Males, 118 females, mean age 44.614.3 yrs; mean BMI 35.46.2) were interviewed by means of SCID I and SCID II. Results – Lifetime Prevalence of Axis I disorders was 58% (males 50%; females 61%); the highest prevalence rate was found for Anxiety Disorders (approx 35%), whilst 30% of subjects were affected by Mood disorders, chiefly Major Depression (20%), and 18% by Eating Disorders. 28% of obese patients presented a Personality Disorder, 23% of patients being affected both by an Axis I and Axis II disorder. Mood Disorders, in particular Major Depression, were significantly prevalent among female obese. 50% of females and approx 37% males included in the sample had contacted mental health units for treatment. Conclusion – Data obtained in the present study confirm the high prevalence rates of mental disorders in obese patients seeking treatment. Specialist units should therefore include thorough psychiatric evaluation of patients as a routine practice.Declaration of Interest: The study was supported by a research grant by University of Cagliari (ex 60% funding, financial year 2006); the authors declare no conflict of interest.

Download Full-text

Mood Disorders in Late Life

The Oxford Handbook of Mood Disorders ◽

10.1093/oxfordhb/9780199973965.013.26 ◽

2016 ◽

pp. 298-310

Author(s):

Pat Arean ◽

Eric Lenze ◽

Joaquin A. Anguera

Keyword(s):

Major Depression ◽

Access To Care ◽

Mood Disorders ◽

Late Life ◽

Later Life ◽

Standardized Assessment ◽

Younger Adults ◽

Assessment Scores ◽

Assessment And Treatment

This chapter discusses how clinicians will need to prepare for a worldwide exponentially growing aging community by describing the current scope of practices with respect to the assessment and treatment mood disorders, including minor and major depression. Particularly for those in later life, the meaningful interpretation of standardized assessment scores requires consideration of medical and neurological complexities. Clinicians must be flexible not only with respect to characterization, but especially with respect to treatment, given the inherent challenges associated with access to care and the range of disability amongst these individuals. Indeed, these late-life individuals are typically assessed in a similar fashion to younger adults (which may obscure meaningful interpretations), making understanding the nuances underlying existing behavioral and pharmaceutical approaches an essential endeavor.

Download Full-text